| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8793260 | Journal of Current Ophthalmology | 2017 | 7 Pages |
Abstract
Administration of topical bevacizumab 4Â mg/ml for two weeks following trabeculectomy with mitomycin-C did not significantly affect the IOP trend, but significantly decreased the cystic bleb formation in short-term follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Reza Zarei, Masoumeh Masoumpour, Sasan Moghimi, Ghasem Fakhraei, Yadollah Eslami, Masoud Mohammadi,